A single dose study evaluating the effect of food on the pharmacokinetics of raltegravir under fed (low- and high-fat) and fasted conditions in healthy volunteers
Latest Information Update: 27 May 2017
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 07 Dec 2013 New trial record
- 16 Oct 2013 Results will be presented at the 14th European AIDS Conference (EACS), according to a media release.